RecallDepth
Class II Ongoing

Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-2510-30

This recall is currently active, issued February 7, 2024. It was issued by Teva Pharmaceuticals Usa, Inc.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
January 8, 2024
Posted
February 7, 2024
Recall Number
D-0275-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
10,672 30-count bottles
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications

Distribution

Nationwide

Lot / Code Info

Lot # 100047273; Exp. 07/2025

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls